aap Implantate AG

Earnings Release • Mar 31, 2006

News Details

Corporate | 31 March 2006 08:00

aap Confirms Successful Turnaround with Consolidated Financial Statements for 2005 and Q1/2006 Sales Figures

Corporate-news transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. —————————————————————————— aap Confirms Successful Turnaround with Consolidated Financial Statements for 2005 and Q1/2006 Sales Figures 2005: 16% Sales Growth, Net Profit for Year, EBITDA EUR 2.3 million Q1/2006: 40% Sales Growth aap Implantate AG, a medical technology company active in the fields of biomaterials and implants for trauma and joint reconstruction, has achieved its forecasts for fiscal 2005 by reporting sales growth of 16% to EUR 13.4 million (previous year: EUR 11.5 million) and a net profit for the year of EUR 655K (previous year: EUR minus 140K). Sales growth adjusted for acquisitions was up 14% to EUR 13.1 million. In EUR million 2005 2004 Change on year Sales revenues 13.4 11.5 +16% EBITDA 2.3 1.2 +93% EBIT/Operating result 0.9 -0.3 n. a. EBT 1.1 -1.3 n. a. Net profit for the year 0.7 -0.1 n. a. Equity (ratio) 19.4 (77%) 15.5 (76%) +25% Balance sheet total 25.1 20.4 +23% Employees 139 109 +28% For fiscal 2005 the Group reported EUR 2.3 million in EBITDA (previous year: EUR 1.2 million). EBT was EUR 1.1 million, or well above the previous year’s EUR minus 1.3 million. The Group’s operating result (EBIT) improved to EUR 855K (previous year: EUR minus 316K). On a balance sheet total of EUR 25.1 million (previous year: EUR 20.4 million) the equity ratio was 77% (previous year: 76%). Preliminary figures show the aap Group to have achieved 40% year-on-year sales growth to EUR 4.4 million (previous year: EUR 3.1 million) in the first quarter of 2006. The first quarter was not affected by special factors. Adjusted for acquisition, organic sales growth was 35%. On the basis of this highly promising start to the new financial year the Management Board plans for 2006 sales growth in excess of 25% and double-digit EBIT and EBT margins. The consolidated financial statements of aap Implantate AG for 2005 are available in full at www.aap.de to download. Publication of the report for the first quarter of 2006 is scheduled for May 15, 2006. Contact: Bei Rückfragen wenden Sie sich bitte an: aap Implantate AG; Nanette Hüdepohl; Investor & Public Relations; Lorenzweg 5; D-12099 Berlin Tel.: ++49/30/750 19 – 133; Fax.: ++49/30/750 19 – 290; n.huedepohl@aap.de (c)DGAP 31.03.2006 ————————————————————————— language: English emitter: aap Implantate AG Lorenzweg 5 12099 Berlin Deutschland phone: +49 (0) 30 75 01 90 fax: +49 (0) 30 75 01 91 11 email: aap@aap.de WWW: www.aap.de ISIN: DE0005066609 WKN: 506660 indexes: stockmarkets: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin-Bremen, Hannover, Düsseldorf, Hamburg, München, Stuttgart End of News DGAP News-Service —————————————————————————